HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats.

Abstract
Despite the clinical reports, few studies have focused on reducing the cardiotoxicity of cisplatin. In the present study, cardiotoxicity was examined after a single ip injection of cisplatin (7mg/kg) in rats. Apocynin was given in drinking water (600mg/L) for five successive days before and after cisplatin injection. At the end of the experiment, hemodynamic parameters were recorded, animals were sacrificed and serum creatine kinase-MB activity was determined. The whole ventricle was isolated for estimation of tumor necrosis factor-alpha (TNF-α) content, NADPH oxidase, myeloperoxidase and caspase-3 activities in addition to nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1) and nuclear factor kappa B (NF-κB) gene expressions. Furthermore, oxidative stress markers and antioxidant enzymes were measured in postmitochondrial and mitochondrial fractions. Mitochondrial membrane potential, nuclear DNA fragmentation and cardiomyocyte cross-sectional area were also evaluated. Apocynin was effective against cisplatin-induced decrement in heart rate and blood pressure. Moreover, pretreatment with apocynin notably ameliorated the state of oxidative stress, mitigated inflammation and preserved mitochondrial membrane potential. Apocynin provided also a significant cardioprotection as revealed by alleviating the overexpression of Nrf2, HO-1 and NF-κB, the elevation of caspase-3 activity, the prominent nuclear DNA fragmentation and the decreased cardiomyocyte cross-sectional area. This study highlights the potential role of apocynin in inhibiting cisplatin-induced hemodynamic changes, postmitochondrial and mitochondrial damage as indicated by improvement in the state of oxidative stress, inflammation and apoptosis.
AuthorsMaha M El-Sawalhi, Lamiaa A Ahmed
JournalChemico-biological interactions (Chem Biol Interact) Vol. 207 Pg. 58-66 (Jan 25 2014) ISSN: 1872-7786 [Electronic] Ireland
PMID24291008 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Chemical References
  • Acetophenones
  • Biomarkers
  • Cardiotonic Agents
  • Enzyme Inhibitors
  • acetovanillone
  • NADPH Oxidases
  • Creatine Kinase
  • Cisplatin
Topics
  • Acetophenones (pharmacology, therapeutic use)
  • Animals
  • Biomarkers (metabolism)
  • Blood Pressure (drug effects)
  • Body Weight (drug effects)
  • Cardiotonic Agents (pharmacology, therapeutic use)
  • Cardiovascular Diseases (blood, chemically induced, drug therapy, enzymology)
  • Cisplatin (adverse effects)
  • Creatine Kinase (blood)
  • Enzyme Inhibitors (pharmacology, therapeutic use)
  • Gene Expression Regulation (drug effects)
  • Heart Rate (drug effects)
  • Male
  • Mitochondria, Heart (drug effects, metabolism)
  • Myocytes, Cardiac (drug effects, metabolism, pathology)
  • NADPH Oxidases (antagonists & inhibitors, metabolism)
  • Oxidative Stress (drug effects)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: